肝内胆管癌淋巴结清扫的热点与争议

doi:10.3969/j.issn.1009-976X.2021.04.001

摘要/Abstract

摘要： 肝内胆管癌是一种高度侵袭性的恶性肿瘤,近年来发病率逐年升高,根治性手术切除被认为是可能治愈的唯一方法。淋巴结转移是手术预后的高危因素,在肝内胆管癌根治性切除术中,淋巴结清扫问题仍存在很多争议,其中淋巴结清扫与否,淋巴结清扫的方式和范围,以及清扫的意义和价值更是当下研究的热点。本文就肝内胆管癌淋巴结清扫的热点与争议进行了讨论。

关键词: 肝内胆管癌, 淋巴结转移, 淋巴结清扫, 诊断, 治疗

Abstract: Intrahepatic cholangiocarcinoma is a highly invasive malignant tumor. In recent years, the incidence has been increasing every year, and radical resection is considered as the only effective way to cure ICC. Lymph node metastasis is an important prognostic risk factor for ICC. In the radical resection of intrahepatic cholangiocarcinoma, the issue of lymph node dissection remains controversial, in which whether lymph node dissection, the way and extent of lymph node dissection, as well as the significance and value of lymph node dissection are the focus of the current research. In this paper, the hotspots and controversies of lymph node dissection for intrahepatic cholangiocarcinoma were discussed.

Key words: intrahepatic cholangiocarcinoma, lymph node metastasis, lymph node dissection, diagnosis, treatment

中图分类号:

R735.7

林志文, 刘红枝, 曾永毅. 肝内胆管癌淋巴结清扫的热点与争议[J]. 岭南现代临床外科, 2021, 21(04): 377-382.

LIN Zhi-wen, LIU Hong-zhi, ZENG Yong-yi. The controversies and hotspots of lymph node dissection for intrahepatic cholangiocarcinoma[J]. Lingnan Modern Clinics In Surgery, 2021, 21(04): 377-382.

参考文献

[1] Wang L, Lin ZG, Ke Q, et al.Adjuvant transarterial chemoembolization following radical resection for intrahepatic cholangiocarcinoma: A multi-center retrospective study[J]. J Cancer, 2020, 11(14): 4115-4122.
[2] 曾永毅, 林自国, 刘红枝, 等. 微血管侵犯对肝内胆管癌根治性切除病人预后影响研究: 基于多中心的倾向评分匹配分析[J]. 中国实用外科杂志, 2020, 40(6): 695-702.
[3] Liao P, Cao L, Chen H, et al.Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study[J]. Medicine (Baltimore), 2021, 100(16): e25635.
[4] Morine Y, Shimada M.The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics[J]. J Gastroenterol, 2015, 50(9): 913-927.
[5] Pupulim LF, Vilgrain V, Ronot M, et al.Hepatic lymphatics: anatomy and related diseases[J]. Abdom Imaging, 2015, 40(6): 1997-2011.
[6] 陆巍, 汤朝晖, 全志伟. 肝内胆管癌淋巴结清扫相关问题的探讨[J]. 中华外科杂志, 2019, 57(4): 247-252.
[7] Lee AJ, Chun YS.Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates[J]. Chin Clin Oncol. 2018,7(5):52.
[8] 王垒,林自国, 杨田, 等. 淋巴结清扫在肝内胆管癌根治术中临床价值的多中心回顾性研究[J]. 中华消化外科杂志, 2020, 19(1): 72-80.
[9] Yin L, Zhao S, Zhu H, et al.Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study[J]. Sci Rep, 2021, 11(1): 12166.
[10] Zhang XF, Xue F, Dong DH, et al. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis [J]. Ann Surg, 2020, Jan 14.[Online ahead of print]
[11] 陈晨,吴予涵,李起,等. 不同淋巴结分期指标评估肝内胆管癌患者预后的价值探讨[J]. 中华外科杂志,2020,58(4):295-302.
[12] Ma K, Dong B, Wang L, et al.Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma[J]. Cancer Manag Res, 2019, 11: 6907-6929.
[13] 白惠惠. 胃癌淋巴结转移的分期与影像学诊断研究进展[J]. 中国临床新医学, 2019, 12(12): 1345-1349.
[14] Jiang L, Tan H, Panje CM, et al.Role of ¹⁸F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma[J]. Clin Nucl Med, 2016, 41(1): 1-7.
[15] Huang X, Yang J, Li J, et al.Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis[J]. Medicine (Baltimore), 2020, 99(35): e20932.
[16] Navarro JG, Lee JH, Kang I, et al.Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection?[J]. HPB (Oxford), 2020, 22(10): 1411-1419.
[17] Lisotti A, Ricci C, Serrani M, et al.Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis[J]. Endosc Int Open, 2019, 7(4): E504-E513.
[18] Malikowski T, Levy MJ, Gleeson FC, et al.Endoscopic Ultrasound/Fine Needle Aspiration Is Effective for Lymph Node Staging in Patients With Cholangiocarcinoma[J]. Hepatology, 2020, 72(3): 940-948.
[19] 於雷,代智,王征,等. 淋巴结转移对肝内胆管细胞癌患者预后的影响及临床相关因素研究[J]. 中国癌症杂志, 2020, 30(9): 694-700.
[20] Meng ZW, Lin XQ, Zhu JH, et al.A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma[J]. J Surg Res, 2018, 226: 56-63.
[21] Ji GW, Zhu FP, Zhang YD, et al.A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma[J]. Eur Radiol, 2019,29(7):3725-3735.
[22] Xu L, Yang P, Liang W, et al.A radiomics approach based on support vector machine using MR images for preoperative lymph node status evaluation in intrahepatic cholangiocarcinoma[J]. Theranostics, 2019, 9(18):5374-5385.
[23] Kizy S, Altman AM, Marmor S, et al.Surgical resection of lymph node positive intrahepatic cholangiocarcinoma may not improve survival[J]. HPB (Oxford), 2019, 21(2): 235-241.
[24] Bridgewater J, Galle PR, Khan SA, et al.Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma[J]. J Hepatol, 2014, 60(6): 1268-1289.
[25] Weber SM, Ribero D, O′Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement[J]. HPB (Oxford), 2015, 17(8): 669-680.
[26] 中国抗癌协会肝癌专业委员会. 中国肝癌多学科综合治疗专家共识[J]. 临床肝胆病杂志, 2021, 37(2): 278-285.
[27] Nakagawa T, Kamiyama T, Kurauchi N, et al.Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma[J]. World J Surg, 2005, 29(6): 728-733.
[28] Yoh T, Hatano E, Nishio T, et al.Significant Improvement in Outcomes of Patients with Intrahepatic Cholangiocarcinoma after Surgery[J]. World J Surg, 2016, 40(9): 2229-2236.
[29] Li DY, Zhang HB, Yang N, et al.Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series[J]. World J Gastroenterol, 2013, 19(47): 9084-9091.
[30] Kang CM, Suh KS, Yi NJ, et al.Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea-Japan Study[J]. Cancers (Basel), 2021, 13(3): 445.
[31] Zhou R, Lu D, Li W, et al.Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis[J]. HPB (Oxford), 2019, 21(7): 784-792.
[32] Shimada M, Yamashita Y, Aishima S, et al.Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma[J]. Br J Surg, 2001, 88(11): 1463-1466.
[33] Nozaki Y, Yamamoto M, Ikai I, et al.Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma[J]. Cancer, 1998, 83(9): 1923-1929.
[34] Yoh T, Cauchy F, Le Roy B, et al.Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study[J]. Surgery, 2019, 166(6): 975-982.
[35] Ke Q, Wang L, Lin Z, et al.Prognostic Value of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma Patients With Clinically Negative Lymph Node Metastasis: A Multi-Center Study From China[J]. Front Oncol, 2021, 11: 585808.
[36] Mazzaferro V, Gorgen A, Roayaie S, et al.Liver resection and transplantation for intrahepatic cholangiocarcinoma[J]. J Hepatol, 2020, 72(2): 364-377.
[37] Bagante F, Gani F, Spolverato G, et al. Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy [J]. J Am Coll Surg, 2015, 221(6): 1031-1040. e1-4.
[38] Hu LS, Zhang XF, Weiss M, et al.Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma[J]. Ann Surg Oncol, 2019, 26(8): 2549-2557.
[39] Hu J, Chen F Y, Zhou K Q, et al.Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection[J]. Oncotarget, 2017, 8(69): 113817-113827.
[40] 黄徐建, 杨发才, 李梦, 等. 肝切除联合淋巴结清扫对临床淋巴结阴性肝内胆管癌患者预后的价值[J]. 中华肝脏外科手术学电子杂志, 2020, 9(6): 533-537.
[41] Benson AB, D′Angelica MI, Abbott DE, et al. Guidelines Insights: Hepatobiliary Cancers, Version 2. 2019[J]. J Natl Compr Canc Netw, 2019, 17(4): 302-310.
[42] 梁后杰,秦叔逵,沈锋,等. CSCO胆道系统肿瘤诊断治疗专家共识(2019年版)[J]. 临床肿瘤学杂志, 2019, 24(9): 828-838.
[43] 王冲,程石. 肝内胆管癌——国内外专家共识及指南解读[J]. 外科理论与实践, 2021, 26(2): 124-129.
[44] Kim DH, Choi DW, Choi SH, et al.Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution[J]. Surgery, 2015, 157(4): 666-675.
[45] Choi SB, Kim KS, Choi JY, et al.The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival[J]. Ann Surg Oncol, 2009, 16(11): 3048-3056.
[46] Kim SH, Han DH, Choi GH, et al.Recommended Minimal Number of Harvested Lymph Nodes for Intrahepatic Cholangiocarcinoma[J]. J Gastrointest Surg, 2021, 25(5): 1164-1171.
[47] Brauer DG, Fields RC, Tan BR Jr, et al.Optimal extent of surgical and pathologic lymph node evaluation for resected intrahepatic cholangiocarcinoma[J]. HPB (Oxford), 2018, 20(5): 470-476.
[48] Martin SP, Drake J, Wach MM, et al.Laparoscopic Approach to Intrahepatic Cholangiocarcinoma is Associated with an Exacerbation of Inadequate Nodal Staging[J]. Ann Surg Oncol, 2019, 26(6): 1851-1857.
[49] Machairas N, Kostakis ID, Schizas D, et al.Meta-analysis of laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma[J]. Updates Surg, 2021, 73(1): 59-68.
[50] 罗柳平, 李建伟, 曹利, 等. 腹腔镜肝切除术治疗肝内胆管癌的临床疗效[J]. 中华消化外科杂志, 2019, 18(2): 169-175.
[51] 张军, 梁博, 付晓伟, 等. 肝内胆管癌根治术不同淋巴结清扫方式对淋巴结检出数目及预后的影响[J]. 中华消化外科杂志, 2020, 19(2): 191-195.
[52] Yamashita Y, Taketomi A, Morita K, et al.The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients[J]. Anticancer Res, 2008, 28(4C): 2353-2359.
[53] Watanabe Y, Matsuyama Y, Izumi N, et al.Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan[J]. Surgery, 2020, 167(5): 793-802.
[54] Farges O, Fuks D, Boleslawski E, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group [J]. Ann Surg, 2011, 254(5): 824-829, discussion 830.
[55] Altman AM, Kizy S, Marmor S, et al.Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus?[J]. Hepatobiliary Surg Nutr, 2020, 9(5): 577-586.
[56] Ke Q, Lin N, Deng M, et al.The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis[J]. PLoS One, 2020, 15(2): e0229292.
[57] Wang L, Lin ZG, Ke Q, et al.Adjuvant transarterial chemoembolization following radical resection for intrahepatic cholangiocarcinoma: A multi-center retrospective study[J]. J Cancer, 2020, 11(14): 4115-4122.
[58] Wang L, Deng M, Ke Q, et al.Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study[J]. Cancer Med, 2020, 9(8): 2674-2685.